DURECT (NASDAQ:DRRX) Given Neutral Rating at HC Wainwright
HC Wainwright restated their neutral rating on shares of DURECT (NASDAQ:DRRX – Free Report) in a research note published on Thursday morning,Benzinga reports. Separately, StockNews.com initiated coverage on DURECT in a research report on Thursday. They set a “sell” rating on the stock. Read Our Latest Report on DRRX DURECT Stock Performance Shares of DRRX […]
